ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 18 filers reported holding ENLIVEX THERAPEUTICS LTD in Q3 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,475 | -50.9% | 12,326 | -18.3% | 0.01% | -84.4% |
| Q2 2023 | $39,689 | -39.0% | 15,091 | -15.5% | 0.03% | -13.5% |
| Q1 2023 | $65,032 | -9.8% | 17,866 | -5.4% | 0.04% | +15.6% |
| Q4 2022 | $72,073 | -15.2% | 18,887 | -7.0% | 0.03% | +14.3% |
| Q3 2022 | $85,000 | -13.3% | 20,299 | -7.7% | 0.03% | +21.7% |
| Q2 2022 | $98,000 | -22.2% | 22,002 | -2.1% | 0.02% | -46.5% |
| Q1 2022 | $126,000 | – | 22,472 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 15,000 | $68,000 | 0.10% |
| Susquehanna International Group Ltd. | 22,002 | $98,000 | 0.02% |
| ARK Investment Management | 331,001 | $1,658,000 | 0.01% |
| Compagnie Lombard Odier SCmA | 50,000 | $223,000 | 0.01% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 13,000 | $59,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 400 | $2,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,215 | $5,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 12,373 | $56,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,884 | $13,000 | 0.00% |